source
- AstraZeneca launches $1.5 billion cost-saving plan to fund growth, says no layoffs expectedAstraZeneca announced a three-year cost‑saving initiative worth $1.5 billion during its third‑quarter earnings call. The program, called Reshaping for Sustainable Growth, aims to redeploy resource…
- Sanofi eyes late-stage and commercial acquisitions to counter upcoming Dupixent revenue dropSanofi said on its third‑quarter earnings call that it is looking to acquire late‑stage and commercial medicines to sustain growth after Dupixent loses exclusivity. CEO Belén Garijo highlighted th…